CVS HEALTH Corp
CVSAPI behind this page
CVS FY 2025 request
Playground key active
/api/financials?ticker=CVS&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.
Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 249,908 | 231,521 | +7.9% |
| Service | 15,175 | 16,239 | -6.6% |
| Premiums Earned Net | 134,751 | 122,896 | +9.6% |
| Net Investment Income | 2,233 | 2,153 | +3.7% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 431 | 395 | +9.1% |
| Corporate/ Other · Corporate/ Other | 431 | 395 | +9.1% |
| Health Care Benefits | 1,782 | 1,473 | +21.0% |
| Health Care Benefits · Operating Segments | 1,782 | 1,473 | +21.0% |
| Health Services | 20 | 285 | -93.0% |
| Health Services · Operating Segments | 20 | 285 | -93.0% |
| Revenue | 402,067 | 372,809 | +7.8% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 484 | 451 | +7.3% |
| Health Care Benefits · Intersegment Elimination | -118 | -72 | -63.9% |
| Health Care Benefits · Operating Segments | 143,354 | 130,665 | +9.7% |
| Health Services · Intersegment Elimination | -25,802 | -15,304 | -68.6% |
| Health Services · Operating Segments | 9,296 | 10,793 | -13.9% |
| Health Services · Operating Segments | 79,334 | 70,877 | +11.9% |
| Health Services · Operating Segments | 101,775 | 91,650 | +11.0% |
| Health Services · Operating Segments | 190,425 | 173,605 | +9.7% |
| Pharmacy & Consumer Wellness · Intersegment Elimination | -45,643 | -41,036 | -11.2% |
| Pharmacy & Consumer Wellness · Operating Segments | 139,367 | 124,500 | +11.9% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -71,563 | -56,412 | -26.9% |
| Operating Segments and Corporate Non-Segment | 473,630 | 429,221 | +10.3% |
| Cost of Revenue | 221,167 | 206,287 | +7.2% |
Show Business Segments breakouts |
|||
| Health Services · Operating Segments | 175,634 | 160,036 | +9.7% |
| Pharmacy & Consumer Wellness · Operating Segments | 113,583 | 99,337 | +14.3% |
| Policyholder Benefits And Claims Incurred Net | 125,538 | 115,121 | +9.0% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 177 | 187 | -5.3% |
| Health Care Benefits · Operating Segments | 122,949 | 113,659 | +8.2% |
| Health Services · Operating Segments | 4,834 | 3,407 | +41.9% |
| Other Cost And Expense Operating | 44,977 | 41,706 | +7.8% |
| Goodwill Impairment Loss | 5,725 | — | — |
Show Business Segments breakouts |
|||
| Health Services | 5,725 | — | — |
| Total Costs & Expenses | 397,407 | 364,293 | +9.1% |
| Operating Income | 4,660 | 8,516 | -45.3% |
| Interest Expense | -3,119 | -2,958 | -5.4% |
| Deconsolidation Gain Or Loss Amount | 483 | — | — |
| Other Non-Operating Income (Expense) | 112 | 99 | +13.1% |
| Income Before Taxes | 2,136 | 6,148 | -65.3% |
| Income Tax Expense (Benefit) | 408 | 1,562 | -73.9% |
| Net Income | 1,728 | 4,586 | -62.3% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -40 | -28 | -42.9% |
| Parent | 1,768 | 4,614 | -61.7% |
| Retained Earnings | 1,768 | 4,614 | -61.7% |
| Net Income Loss Attributable To Noncontrolling Interest | 40 | 28 | +42.9% |
| Net Income | 1,768 | 4,614 | -61.7% |
| EPS (Basic) | 1.4 | 3.67 | -61.9% |
| EPS (Diluted) | 1.39 | 3.66 | -62.0% |
| Wtd Avg Shares (Basic) | 1,267 | 1,259 | +0.6% |
| Wtd Avg Shares (Diluted) | 1,271 | 1,262 | +0.7% |
| Comprehensive Income | 2,294 | 4,791 | -52.1% |
| Net Income Loss Available To Common Stockholders Basic | 1,768 | 4,614 | -61.7% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 125,274 | 114,827 | +9.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 8,453 | 8,586 | -1.5% |
| Short-Term Investments | 2,145 | 2,407 | -10.9% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 1,997 | 2,256 | -11.5% |
| Mortgage loans | 148 | 151 | -2.0% |
| Accounts Receivable | 39,779 | 36,469 | +9.1% |
| Inventory | 19,246 | 18,107 | +6.3% |
| Other Assets Current | 5,091 | 3,076 | +65.5% |
| Total Current Assets | 74,714 | 68,645 | +8.8% |
| Non-Current Assets | |||
| Long Term Investments | 32,669 | 28,934 | +12.9% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 26,721 | 23,777 | +12.4% |
| Mortgage loans | 1,376 | 1,354 | +1.6% |
| Other Investments | 4,572 | 3,803 | +20.2% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Not Primary Beneficiary | 3,169 | 2,618 | +21.0% |
| Variable Interest Entity Not Primary Beneficiary · Hedge Funds | 1,684 | 1,246 | +35.2% |
| Variable Interest Entity Not Primary Beneficiary · Private Equity Funds | 905 | 934 | -3.1% |
| Variable Interest Entity Not Primary Beneficiary · Real Estate Funds | 580 | 438 | +32.4% |
| Operating Lease Right-of-Use Assets | 14,973 | 15,944 | -6.1% |
| Goodwill | 85,478 | 91,272 | -6.3% |
Show Business Segments breakouts |
|||
| Health Care Benefits | 46,644 | 46,644 | 0.0% |
| Health Services | 28,272 | 34,066 | -17.0% |
| Pharmacy & Consumer Wellness | 10,562 | 10,562 | 0.0% |
Show Reporting Unit breakouts |
|||
| Health Care Delivery Reporting Unit | 4.2 | — | — |
| Other Non-Current Assets | 5,119 | 4,793 | +6.8% |
| Total Assets | 253,538 | 253,215 | +0.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity, Primary Beneficiary, Physicians Groups | 2,975 | 2,144 | +38.8% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Related Intangible Assets | 11,573 | 13,015 | -11.1% |
| Other Intangible Assets | 371 | 444 | -16.4% |
| Provider networks | 2,711 | 2,921 | -7.2% |
| Technology Based Intangible Assets | 20 | 83 | -75.9% |
| Value of Business Acquired | 335 | 362 | -7.5% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 13,083 | 12,993 | +0.7% |
| Intangible Assets Net Excluding Goodwill | 25,508 | 27,323 | -6.6% |
| Separate Account Assets | 1,994 | 3,311 | -39.8% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Cash And Cash Equivalents | 1 | 1 | 0.0% |
| Fair Value Inputs Level1 · Debt Securities | 30 | 186 | -83.9% |
| Fair Value Inputs Level1 · Total | 31 | 187 | -83.4% |
| Fair Value Inputs Level2 · Cash And Cash Equivalents | 155 | 164 | -5.5% |
| Fair Value Inputs Level2 · Common/collective trusts | 1,445 | 2,478 | -41.7% |
| Fair Value Inputs Level2 · Debt Securities | 361 | 669 | -46.0% |
| Fair Value Inputs Level2 · Total | 1,961 | 3,311 | -40.8% |
| Fair Value Inputs Level3 · Debt Securities | 2 | 1 | +100.0% |
| Fair Value Inputs Level3 · Total | 2 | 1 | +100.0% |
Show Financial Instrument breakouts |
|||
| Commercial Mortgage Backed Securities · Separate Account Mortgage Backed Security | 3 | 3 | 0.0% |
| Domestic Corporate Debt Securities · Separate Account Debt Security | 291 | 524 | -44.5% |
| Foreign Corporate Debt Securities · Separate Account Debt Security | 39 | 51 | -23.5% |
| Residential Mortgage Backed Securities · Separate Account Mortgage Backed Security | 8 | 71 | -88.7% |
| US Government Agencies Debt Securities · Separate Account Debt Security | 36 | 186 | -80.6% |
| US States And Political Subdivisions · Separate Account Debt Security | 11 | 14 | -21.4% |
Show Separate Account Asset Category breakouts |
|||
| Cash And Cash Equivalents | 156 | 165 | -5.5% |
| Common/collective trusts | 1,445 | 2,478 | -41.7% |
| Debt Securities | 393 | 856 | -54.1% |
| Other asset-backed securities | 5 | 7 | -28.6% |
| Separate Account Cash And Cash Equivalents | 156 | 165 | -5.5% |
| Separate Account Debt Security | 393 | 856 | -54.1% |
| Total | 1,994 | 3,499 | -43.0% |
| Current Liabilities | |||
| Accounts Payable Trade Current | 17,641 | 15,892 | +11.0% |
| Pharmacy Claims And Discounts Payable Current | 26,344 | 24,166 | +9.0% |
| Accrued Liabilities | 22,387 | 20,810 | +7.6% |
| Other Insurance Liabilities Current | 1,116 | 1,183 | -5.7% |
| Operating Lease Liability Current | 1,737 | 1,751 | -0.8% |
| Long Term Debt And Capital Lease Obligations Current | 4,068 | 3,624 | +12.3% |
| Total Current Liabilities | 88,692 | 84,609 | +4.8% |
| Deferred Revenue (Current) | 62 | 144 | -56.9% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 13,643 | 14,899 | -8.4% |
| Deferred Tax Liabilities | 3,832 | 3,806 | +0.7% |
| Other Insurance Liabilities Noncurrent | 4,716 | 4,902 | -3.8% |
| Other Non-Current Liabilities | 4,777 | 5,431 | -12.0% |
| Total Liabilities | 178,156 | 177,485 | +0.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity, Primary Beneficiary, Physicians Groups | 3,170 | 2,104 | +50.7% |
| Other Liabilities | |||
| Liability For Claims And Claims Adjustment Expense And Health Care Organization Accounts Payable To Third Party Payor | 15,399 | 15,064 | +2.2% |
| Long Term Debt And Capital Lease Obligations | 60,502 | 60,527 | -0.0% |
| Separate Accounts Liability | 1,994 | 3,311 | -39.8% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 50,402 | 49,661 | +1.5% |
| Treasury Stock Common Value | -36,790 | -36,818 | +0.1% |
| Retained Earnings | 61,196 | 62,837 | -2.6% |
| Accumulated Other Comprehensive Income | 406 | -120 | +438.3% |
| Total Stockholders' Equity | 75,214 | 75,560 | -0.5% |
| Minority Interest | 168 | 170 | -1.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 75,382 | 75,730 | -0.5% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Gain Loss Including Portion Attributable To Noncontrolling Interest | -238 | -211 | -12.8% |
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | 7 | -4 | +275.0% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | 216 | 229 | -5.7% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | 206 | -399 | +151.6% |
| Accumulated Other Comprehensive Income | 406 | -120 | +438.3% |
| Aoci Including Portion Attributable To Noncontrolling Interest | 406 | -120 | +438.3% |
| Change in discount rate on long-duration insurance reserves | 215 | 265 | -18.9% |
| Common Stock | 18 | 18 | 0.0% |
| Common Stock Including Additional Paid In Capital | 50,402 | 49,661 | +1.5% |
| Noncontrolling Interest | 168 | 170 | -1.2% |
| Parent | 75,214 | 75,560 | -0.5% |
| Retained Earnings | 61,196 | 62,837 | -2.6% |
| Treasury Stock Common | -36,790 | -36,818 | +0.1% |
| Total Liabilities & Equity | 253,538 | 253,215 | +0.1% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Proceeds From Customers | 389,128 | 357,995 | +8.7% |
| Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies | -216,493 | -197,726 | -9.5% |
| Payments For Insurance Benefits | -121,238 | -109,464 | -10.8% |
| Payments To Suppliers And Employees | -37,570 | -38,821 | +3.2% |
| Proceeds From Interest And Dividends Received | 1,969 | 1,735 | +13.5% |
| Interest Paid | -2,991 | -2,909 | -2.8% |
| Income Taxes Paid | -2,166 | -1,703 | -27.2% |
| Net Cash from Operations | 10,639 | 9,107 | +16.8% |
| Depreciation & Amortization | 4,606 | 4,597 | +0.2% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 415 | 396 | +4.8% |
| Health Care Benefits | 1,579 | 1,599 | -1.3% |
| Health Services | 1,039 | 1,059 | -1.9% |
| Pharmacy & Consumer Wellness | 1,573 | 1,543 | +1.9% |
| Stock-Based Compensation | 535 | 540 | -0.9% |
| Gain Loss On Sale Of Business | 236 | — | — |
Show Business Segments breakouts |
|||
| Health Services · Disposal Group Disposed Of By Sale Not Discontinued Operations | 236 | — | — |
| Deferred Income Taxes And Tax Credits | 102 | -572 | +117.8% |
| Other Non-Cash Items | -336 | -502 | +33.1% |
| Deferred Income Taxes | 102 | -572 | +117.8% |
| Investing Activities | |||
| Proceeds From Sale And Maturity Of Marketable Securities | 12,383 | 10,353 | +19.6% |
| Payments To Acquire Investments | -15,012 | -15,191 | +1.2% |
| Capital Expenditures | -2,832 | -2,781 | -1.8% |
| Payments To Acquire Businesses Net Of Cash Acquired | -436 | -95 | -358.9% |
| Other Investing Activities | 26 | 101 | -74.3% |
| Net Cash from Investing | -5,871 | -7,613 | +22.9% |
| Financing Activities | |||
| Proceeds From Repayments Of Commercial Paper | -2,119 | 1,919 | -210.4% |
| Proceeds From Issuance Of Long Term Debt | 3,969 | 7,913 | -49.8% |
| Repayments Of Long Term Debt | -3,629 | -4,773 | +24.0% |
| Payments Of Dividends | -3,397 | -3,373 | -0.7% |
| Proceeds From Stock Options Exercised | 394 | 361 | +9.1% |
Show Award Type breakouts |
|||
| Stock options and SARs | 394 | 361 | +9.1% |
| Tax Withholding for Share Compensation | -158 | -185 | +14.6% |
Show Award Type breakouts |
|||
| Stock options and SARs | -158 | -185 | +14.6% |
| Net Cash from Financing | -4,940 | -1,135 | -335.2% |
| Supplemental | |||
| Change in Accounts Receivable | -3,498 | -1,301 | -168.9% |
| Change in Inventory | -1,267 | -102 | -1142.2% |
| Increase Decrease In Other Operating Assets | -2,593 | -38 | -6723.7% |
| Change in Accounts Payable | 3,855 | 2,335 | +65.1% |
| Increase Decrease In Insurance Liabilities | 16 | 2,757 | -99.4% |
| Increase Decrease In Other Operating Liabilities | 2,013 | -3,542 | +156.8% |
| Other Cash Flow | |||
| Net Change in Cash | -172 | 359 | -147.9% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 8,712 | 8,884 | -1.9% |
Values in millions USD. Source: SEC EDGAR 10-K filing.